ADVFN ADVFN

Hot Features

Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Outlook Therapeutics Inc

Outlook Therapeutics Inc (OTLK)

0.89
0.1853
(26.29%)
終了 6月11日 5:00AM
0.9211
0.0311
(3.49%)
取引時間後: 8:59AM

Outlook Therapeutics Inc (OTLK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.9211
( 30.71% )
買値
0.9111
売値
0.9212
出来高
23,161,092
0.6939 日の範囲 0.905
0.1611 52 週間の範囲 3.39
時価総額
前日終値
0.7047
始値
0.6939
最終取引時間
財務取引量
US$ 19,135,921
VWAP
0.82621
平均取引量 (3 か月)
US$ 14,679,204
発行済株式数
120,863,252
配当利回り
PER
-0.72
1 株当たり利益 (EPS)
-1.08
歳入
333.14k
純利益
-60.96M

Outlook Therapeutics Inc について

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that ... Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Iselin, United States
設立
2026
Outlook Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker OTLK. The last closing price for Outlook Therapeutics was US$0.70. Over the last year, Outlook Therapeutics shares have traded in a share price range of US$ 0.1611 to US$ 3.39.

Outlook Therapeutics currently has 120,863,252 shares in issue. The market capitalisation of Outlook Therapeutics is US$111.33 million. Outlook Therapeutics has a price to earnings ratio (PE ratio) of -0.72.

OTLK 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.120114.99375780270.80110.67521100429040.76763823CS
40.6861291.9574468090.23510.215383205940.54080323CS
120.5311136.1794871790.3910.1611159148500.48004072CS
26-1.1689-55.92822966512.092.53750.1611102176790.59314035CS
52-0.9789-51.52105263161.93.390.161166079780.8110323CS
156-0.8089-46.75722543351.7312.84990.161137956310.94429924CS
260-1.6889-64.70881226052.6112.84990.161127476071.08963039CS

OTLK - Frequently Asked Questions (FAQ)

What is the current Outlook Therapeutics Inc share price?
The current share price of Outlook Therapeutics Inc is US$ 0.9211
How many Outlook Therapeutics Inc shares are in issue?
Outlook Therapeutics Inc has 120,863,252 shares in issue
What is the market cap of Outlook Therapeutics Inc?
The market capitalisation of Outlook Therapeutics Inc is USD 111.33M
What is the 1 year trading range for Outlook Therapeutics Inc share price?
Outlook Therapeutics Inc has traded in the range of US$ 0.1611 to US$ 3.39 during the past year
What is the PE ratio of Outlook Therapeutics Inc?
The price to earnings ratio of Outlook Therapeutics Inc is -0.72
What is the cash to sales ratio of Outlook Therapeutics Inc?
The cash to sales ratio of Outlook Therapeutics Inc is 281.79
What is the registered address of Outlook Therapeutics Inc?
The registered address for Outlook Therapeutics Inc is 111 S. Wood Avenue, Iselin, New Jersey, 08830
What is the Outlook Therapeutics Inc website address?
The website address for Outlook Therapeutics Inc is outlooktherapeutics.com
Which industry sector does Outlook Therapeutics Inc operate in?
Outlook Therapeutics Inc operates in the Biotechnology & Life Sciences sector

OTLK 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

OTLK Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock